Dechra Pharmaceuticals (DCHPF) Stock Price, News & Analysis

Company Overview

Dechra Pharmaceuticals plc is a specialty veterinary pharmaceutical company headquartered in the United Kingdom. The company develops, manufactures and markets medicines and related products for veterinary surgeons, supporting the treatment of companion animals, horses and food-producing animals.

Its product portfolio covers therapeutic areas including endocrinology, dermatology, anesthesia and analgesia, cardiology, gastroenterology, infectious diseases and critical care. Dechra also provides veterinary diets and other specialized products intended to help manage animal health conditions.

Founded in 1997, Dechra expanded through product development, acquisitions and international commercialization. Its operations and products serve veterinary markets across Europe, North America and other regions worldwide. In 2023, Dechra was acquired by EQT and subsequently delisted from the London Stock Exchange, becoming a privately held company.

Key Stats

• Today's Range: $46.90 to $46.90
• 50-Day Range: $46.90 to $46.90
• 52-Week Range: $30.00 to $47.40
• Volume: N/A
• Average Volume: 1,687 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:DCHPF
• CIK: N/A
• Web: dechra.com
• Phone: 441606814730
• Fax: N/A
• Employees: 2,457
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A